Nasdaq · CIK 0001681622
VREX Varex Imaging Corp
Insider trading from SEC Form 4. Last filing 28 d ago. Close $18.46 on Oct 9, 2026, +98% from the 52-week low and -1% from the high.
In brief
Varex Imaging Corp (VREX) has 60 SEC Form 4 filings on file from 13 insiders, the latest filed on Sep 15, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 2 open-market sells worth $2.6M, net -$2.6M.
9 open-market trades have been scored at VREX. The newest: Jay K. Kunkel (director) sold $150k of stock on Sep 14, 2026, filed Sep 15, 2026, scored 44 (moderate). The largest of the 9 shown: Shubham Maheshwari (Chief Financial Officer) sold $2.4M on Sep 11, 2026, scored 50 (moderate). 2 insiders sold within 14 days of each other around Sep 14, 2026.
12 Form 144 notices of planned sales are on file, the latest filed Sep 14, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Varex Imaging Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Jay K. Kunkel director sell | $150k 8,121 shares | -35% | - | |
| 50Moderate | Shubham Maheshwari Chief Financial Officer sell | $2.4M 130,000 shares | -48% | - | |
| 27Weak | Jay K. Kunkel director sell | $50k 4,510 shares | -16% | +55% from low-26% from high | |
| 21Weak | Karen L Aranki Chief Human Resources Officer sell | $39k 3,174 shares | -95% | +78% from low-26% from high | |
| 25Weak | Jay K. Kunkel director sell | $31k 3,000 shares | -13% | +57% from low-35% from high | |
| 20Weak | Jay K. Kunkel director sell | $20k 2,575 shares | -10% | +11% from low-54% from high | |
| 23Weak | Sunny Sanyal President and CEO sell | $98k 8,749 shares | -4% | +6% from low-31% from high | |
| 30Weak | Kimberley E. Honeysett SVP and CLO sell | $51k 4,007 shares | -50% | +19% from low-23% from high | |
| 45Moderate | Kimberley E. Honeysett SVP and General Counsel sell | $122k 6,174 shares | -100% | +14% from low-17% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 14, 2026 | Kunkel Jay K. Director | 8,121 0.02% of outstanding | $150k | Sep 14, 2026 | none |
| Sep 11, 2026 | Maheshwari Shubham Officer | 130,000 0.31% of outstanding | $2.4M | Sep 11, 2026 | none |
| Mar 20, 2026 | Kunkel Jay K. Director | 4,510 0.01% of outstanding | $50k | Mar 20, 2026 | none |
| Dec 11, 2025 | Honeysett Kimberley E. Officer | 4,000 0.01% of outstanding | $47k | Dec 11, 2025 | $41k |
| Nov 21, 2025 | Honeysett Kimberley E. Officer | 4,000 0.01% of outstanding | $41k | Nov 21, 2025 | none |
| Sep 19, 2025 | Aranki Karen L Officer | 3,174 0.01% of outstanding | $39k | Sep 19, 2025 | none |
| Aug 14, 2025 | Kunkel Jay K. Director | 3,000 0.01% of outstanding | $31k | Aug 14, 2025 | $20k |
| Jun 18, 2025 | Kunkel Jay K. Director | 2,575 0.01% of outstanding | $20k | Jun 18, 2025 | none |
| Apr 2, 2025 | SANYAL SUNNY Officer, Director | 8,749 0.02% of outstanding | $98k | Apr 2, 2025 | none |
| Mar 20, 2025 | Honeysett Kimberley E. Officer | 4,007 0.01% of outstanding | $51k | Mar 20, 2025 | none |
| Mar 15, 2024 | Honeysett Kimberley E. Officer | 2,860 0.01% of outstanding | $50k | Mar 15, 2024 | none |
| Nov 22, 2023 | Honeysett Kimberley E. Officer | 6,174 0.02% of outstanding | $122k | Nov 22, 2023 | none |
Transactions
The newest 50 of 146 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Shubham Maheshwari Chief Financial Officer | MOption exercise Common Stock | +160,944 | $13.61 | $2.2M | 269,972 | 28 d ago |
| Sep 14, 2026 | Jay K. Kunkel director | SOpen-market sale Common Stock | -8,121 | $18.48 | $150k | 15,329 | 28 d ago |
| Sep 11, 2026 | Shubham Maheshwari Chief Financial Officer | SOpen-market sale Common Stock | -130,000 | $18.46 | $2.4M | 139,972 | 28 d ago |
| Sep 11, 2026 | Shubham Maheshwari Chief Financial Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -160,944 | $0.00 | $0 | 0 | 28 d ago |
| Aug 14, 2026 | Karen L Aranki Chief Human Resources Officer | MOption exercise Common Stock | +3,974 | - | - | 8,893 | Aug 18, 2026 |
| Aug 14, 2026 | Karen L Aranki Chief Human Resources Officer | FTax withholding Common Stock | -1,145 | $18.49 | $21k | 7,748 | Aug 18, 2026 |
| Aug 14, 2026 | Karen L Aranki Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative | -3,974 | $0.00 | $0 | 3,975 | Aug 18, 2026 |
| Mar 20, 2026 | Jay K. Kunkel director | SOpen-market sale Common Stock | -4,510 | $11.14 | $50k | 23,450 | Mar 23, 2026 |
| Feb 12, 2026 | Jocelyn D Chertoff director | AGrant or award Deferred Stock Unitsderivative | +12,331 | $0.00 | $0 | 12,331 | Feb 13, 2026 |
| Feb 12, 2026 | Kathleen Bardwell director | AGrant or award Deferred Stock Unitsderivative | +12,331 | $0.00 | $0 | 12,331 | Feb 13, 2026 |
| Feb 12, 2026 | Jay K. Kunkel director | AGrant or award Deferred Stock Unitsderivative | +12,331 | $0.00 | $0 | 12,331 | Feb 13, 2026 |
| Feb 12, 2026 | Timothy E Guertin director | AGrant or award Deferred Stock Unitsderivative | +12,331 | $0.00 | $0 | 12,331 | Feb 13, 2026 |
| Feb 12, 2026 | Walter M Rosebrough Jr director | AGrant or award Deferred Stock Unitsderivative | +14,947 | $0.00 | $0 | 14,947 | Feb 13, 2026 |
| Feb 12, 2026 | Christine A Tsingos director | AGrant or award Deferred Stock Unitsderivative | +12,331 | $0.00 | $0 | 12,331 | Feb 13, 2026 |
| Feb 9, 2026 | Jay K. Kunkel director | MOption exercise Common Stock | +8,483 | - | - | 27,960 | Feb 10, 2026 |
| Feb 9, 2026 | Jay K. Kunkel director | MOption exercise Deferred Stock Unitsderivative | -8,483 | $0.00 | $0 | 0 | Feb 10, 2026 |
| Feb 9, 2026 | Jocelyn D Chertoff director | MOption exercise Common Stock | +8,483 | - | - | 42,194 | Feb 9, 2026 |
| Feb 9, 2026 | Timothy E Guertin director | MOption exercise Common Stock | +8,483 | - | - | 26,777 | Feb 9, 2026 |
| Feb 9, 2026 | Christine A Tsingos director | MOption exercise Common Stock | +8,483 | - | - | 42,655 | Feb 9, 2026 |
| Feb 9, 2026 | Walter M Rosebrough Jr director | MOption exercise Common Stock | +10,339 | - | - | 52,654 | Feb 9, 2026 |
| Feb 9, 2026 | Kathleen Bardwell director | MOption exercise Common Stock | +8,483 | - | - | 12,102 | Feb 9, 2026 |
| Feb 9, 2026 | Kathleen Bardwell director | MOption exercise Deferred Stock Unitsderivative | -8,483 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Feb 9, 2026 | Jocelyn D Chertoff director | MOption exercise Deferred Stock Unitsderivative | -8,483 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Feb 9, 2026 | Timothy E Guertin director | MOption exercise Deferred Stock Unitsderivative | -8,483 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Feb 9, 2026 | Walter M Rosebrough Jr director | MOption exercise Deferred Stock Unitsderivative | -10,339 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Feb 9, 2026 | Christine A Tsingos director | MOption exercise Deferred Stock Unitsderivative | -8,483 | $0.00 | $0 | 0 | Feb 9, 2026 |
| Dec 15, 2025 | Shubham Maheshwari Chief Financial Officer | AGrant or award Performance Stock Unitsderivative | +4,515 | $0.00 | $0 | 7,354 | Dec 17, 2025 |
| Dec 15, 2025 | Sunny Sanyal President and CEO | AGrant or award Performance Stock Unitsderivative | +15,394 | $0.00 | $0 | 25,075 | Dec 17, 2025 |
| Dec 15, 2025 | Karen L Aranki Chief Human Resources Officer | AGrant or award Performance Stock Unitsderivative | +2,155 | $0.00 | $0 | 3,510 | Dec 17, 2025 |
| Dec 15, 2025 | Andrew Hartmann SVP and GM, Detectors | AGrant or award Performance Stock Unitsderivative | +2,565 | $0.00 | $0 | 4,178 | Dec 17, 2025 |
| Dec 15, 2025 | Mark S. Jonaitis SVP and GM, X-Ray Sources | AGrant or award Performance Stock Unitsderivative | +2,565 | $0.00 | $0 | 4,178 | Dec 17, 2025 |
| Dec 15, 2025 | Mark S. Jonaitis SVP and GM, X-Ray Sources | AGrant or award Performance Stock Unitsderivative | +3,134 | $0.00 | $0 | 3,134 | Dec 17, 2025 |
| Dec 15, 2025 | Shubham Maheshwari Chief Financial Officer | AGrant or award Performance Stock Unitsderivative | +5,520 | $0.00 | $0 | 5,520 | Dec 17, 2025 |
| Dec 15, 2025 | Sunny Sanyal President and CEO | AGrant or award Performance Stock Unitsderivative | +18,801 | $0.00 | $0 | 18,801 | Dec 17, 2025 |
| Dec 15, 2025 | Karen L Aranki Chief Human Resources Officer | AGrant or award Performance Stock Unitsderivative | +2,633 | $0.00 | $0 | 2,633 | Dec 17, 2025 |
| Dec 15, 2025 | Andrew Hartmann SVP and GM, Detectors | AGrant or award Performance Stock Unitsderivative | +3,134 | $0.00 | $0 | 3,134 | Dec 17, 2025 |
| Dec 10, 2025 | Sunny Sanyal President and CEO | MOption exercise Common Stock | +26,652 | - | - | 216,845 | Dec 12, 2025 |
| Dec 10, 2025 | Karen L Aranki Chief Human Resources Officer | MOption exercise Common Stock | +6,665 | - | - | 6,842 | Dec 12, 2025 |
| Dec 10, 2025 | Shubham Maheshwari Chief Financial Officer | MOption exercise Common Stock | +7,063 | - | - | 98,152 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew Hartmann SVP and GM, Detectors | MOption exercise Common Stock | +4,664 | - | - | 31,883 | Dec 12, 2025 |
| Dec 10, 2025 | Mark S. Jonaitis SVP and GM, X-Ray Sources | MOption exercise Common Stock | +4,664 | - | - | 74,932 | Dec 12, 2025 |
| Dec 10, 2025 | Matthew Aaron Martinez Chief Legal Officer | AGrant or award Restricted Stock Unitsderivative | +17,094 | $0.00 | $0 | 17,094 | Dec 12, 2025 |
| Dec 10, 2025 | Karen L Aranki Chief Human Resources Officer | FTax withholding Common Stock | -1,923 | $11.70 | $22k | 4,919 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew Hartmann SVP and GM, Detectors | MOption exercise Common Stock | +7,935 | - | - | 39,818 | Dec 12, 2025 |
| Dec 10, 2025 | Sunny Sanyal President and CEO | MOption exercise Common Stock | +47,613 | - | - | 264,458 | Dec 12, 2025 |
| Dec 10, 2025 | Shubham Maheshwari Chief Financial Officer | MOption exercise Common Stock | +13,966 | - | - | 112,118 | Dec 12, 2025 |
| Dec 10, 2025 | Mark S. Jonaitis SVP and GM, X-Ray Sources | MOption exercise Common Stock | +7,935 | - | - | 82,867 | Dec 12, 2025 |
| Dec 10, 2025 | Karen L Aranki Chief Human Resources Officer | MOption exercise Restricted Stock Unitsderivative | -6,665 | $0.00 | $0 | 6,666 | Dec 12, 2025 |
| Dec 10, 2025 | Andrew Hartmann SVP and GM, Detectors | FTax withholding Common Stock | -3,636 | $11.70 | $43k | 36,182 | Dec 12, 2025 |
| Dec 10, 2025 | Shubham Maheshwari Chief Financial Officer | FTax withholding Common Stock | -5,227 | $11.70 | $61k | 106,891 | Dec 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Karen L ArankiChief Human Resources Officer
- Kathleen Bardwelldirector
- Jocelyn D Chertoffdirector
- Timothy E Guertindirector
- Andrew HartmannSVP Sales & Marketing, Medical
- Kimberley E. HoneysettSVP and General Counsel
- Mark S. JonaitisSVP and GM, X-Ray Sources
- Jay K. Kunkeldirector
- Shubham MaheshwariChief Financial Officer
- Matthew Aaron MartinezChief Legal Officer
- Walter M Rosebrough Jrdirector
- Sunny SanyalPresident and CEO
- Christine A Tsingosdirector
Questions about VREX
Answered from the filings on this page, as of the latest one.
Are insiders buying VREX?
As of Sep 15, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 2 open-market sells worth $2.6M by 2 insiders at Varex Imaging Corp in the last 90 days, net -$2.6M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade VREX on the open market?
Jay K. Kunkel (director) sold $150k of VREX on Sep 14, 2026 and filed the Form 4 on Sep 15, 2026. InsiderTell scored 44 (moderate), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Varex Imaging Corp?
13 people have filed a Form 4 at Varex Imaging Corp, among them Karen L Aranki (Chief Human Resources Officer), Kathleen Bardwell (director), Jocelyn D Chertoff (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.